Comparing Immediate Removal and Postoperative 1 Day of Urinary Catheter After Colorectal Cancer S… (NCT06769087) | Clinical Trial Compass
By InvitationNot Applicable
Comparing Immediate Removal and Postoperative 1 Day of Urinary Catheter After Colorectal Cancer Surgery
South Korea316 participantsStarted 2024-12-01
Plain-language summary
The enhanced recovery after surgery (ERAS) program is widely applied in colorectal cancer surgery. Among the early recovery programs after surgery, the timing of removal of the urinary catheter after surgery has been emphasized recently, but the specific timing is still under discussion. Maintaining the urinary catheter after surgery is to prevent urinary retention after surgery, but it is known that the risk of urinary tract infection increases the longer it is maintained. Previously, it was removed 3 days after colorectal cancer surgery, but several studies reported that even if it was removed earlier, the incidence of urinary retention did not increase, and rather the incidence of urinary tract infection decreased. In particular, by applying the early recovery program after surgery, factors related to patient recovery before, during, and after surgery are applied to help rapid recovery, and it has been reported that early removal of the urinary catheter has a positive effect on postoperative recovery and complications. Therefore, it is necessary to prove that the timing of removal of the urinary catheter after surgery in colorectal cancer patients can help early recovery through clinical results such as patient recovery and occurrence of complications.
Who can participate
Age range
19 Years – 80 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* 19 years old 80 years old
* Patients diagnosed with colorectal cancer who are eligible for radical resection surgery
* Patients who underwent open, laparoscopic, or robotic surgery
* Written informed consent
Exclusion Criteria:
* Patients who have undergone two or more major abdominal surgeries, including lateral pelvic lymph node dissection, at the same time
* Patients who require continuous monitoring through a urinary catheter due to hemodynamic instability or massive bleeding, etc.
* Patients who have undergone conventional treatment in cases other than distant metastasis or R0 resection
* Patients who have developed complications related to the urinary system during surgery and require maintenance of a urinary catheter such as a urethral stent
* Patients who have undergone urinary surgery such as urethral stent placement, cystectomy, or urostomy in the past
* Patients who are on hemodialysis or peritoneal dialysis due to chronic renal failure
* Patients who cannot participate in a clinical trial at the discretion of a physician
* Patients who do not wish to participate in the study
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Incidence of acute urinary retention due to failure to void spontaneously within 4 hours after removal of a urinary drain